Unknown

Dataset Information

0

The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.


ABSTRACT: Rearrangement of chromosomal bands 1q21-23 is one of the most frequent chromosomal aberrations observed in hematological malignancy. The genes affected by these rearrangements remain poorly characterized. Typically, 1q21-23 rearrangements arise during tumor evolution and accompany disease-specific chromosomal rearrangements such as t(14;18) (BCL2) and t(8;14) (MYC), where they are thus thought to play an important role in tumor progression. The pathogenetic basis of this 1q21-23-associated disease progression is currently unknown. In this setting, we surveyed our series of follicular lymphoma for evidence of recurring 1q21-23 breaks and identified three cases in which a t(14;18)(q32;q21) was accompanied by a novel balanced t(1;22)(q22;q11). Molecular cloning of the t(1;22) in a cell line (B593) derived from one of these cases and detailed fluorescent in situ hybridization mapping in the two remaining cases identified the FCGR2B gene, which encodes the immunoreceptor tyrosine-based inhibition motif-bearing IgG Fc receptor, FcgammaRIIB, as the target gene of the t(1;22)(q22;q11). We demonstrate deregulation of FCGR2B leading to hyperexpression of FcgammaRIIb2 as the principal consequence of the t(1;22). This is evidence that IgG Fc receptors can be targets for deregulation through chromosomal translocation in lymphoma. It suggests that dysregulation of FCGR2B may play a role in tumor progression in follicular lymphoma.

SUBMITTER: Callanan MB 

PROVIDER: S-EPMC26659 | biostudies-literature | 2000 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Callanan M B MB   Le Baccon P P   Mossuz P P   Duley S S   Bastard C C   Hamoudi R R   Dyer M J MJ   Klobeck G G   Rimokh R R   Sotto J J JJ   Leroux D D  

Proceedings of the National Academy of Sciences of the United States of America 20000101 1


Rearrangement of chromosomal bands 1q21-23 is one of the most frequent chromosomal aberrations observed in hematological malignancy. The genes affected by these rearrangements remain poorly characterized. Typically, 1q21-23 rearrangements arise during tumor evolution and accompany disease-specific chromosomal rearrangements such as t(14;18) (BCL2) and t(8;14) (MYC), where they are thus thought to play an important role in tumor progression. The pathogenetic basis of this 1q21-23-associated disea  ...[more]

Similar Datasets

| S-EPMC2910394 | biostudies-literature
| S-EPMC3225846 | biostudies-literature
| S-EPMC286611 | biostudies-other
| S-EPMC7531492 | biostudies-literature
| S-EPMC3050502 | biostudies-literature
| S-EPMC5749535 | biostudies-literature
| S-EPMC3660407 | biostudies-literature
| S-EPMC3288289 | biostudies-literature
| S-EPMC5623700 | biostudies-literature
| S-EPMC6601554 | biostudies-literature